CompletedPhase 2/3

RAE (Realize, Analyze, Engage)

United States209 participantsStarted 2022-02-22

Plain-language summary

The proposed study will evaluate the detection of digital biomarkers of stress, and drug craving in a population of individuals undergoing treatment for substance use disorder

Who can participate

Age range18 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * 18 years or older * Enrolled in an outpatient SUD treatment program * Enrolled in treatment for \< 90 days * Fluent in English * Have access to a smartphone with iOS or Android Capabilities * Capable of providing informed consent Exclusion Criteria: * Pregnancy * Prisoner Status * Significant limitation of range of motion of non-dominant arm (amputation or fracture)

What they're measuring

Number of participants with return to drug use

Timeframe: 3 months

Trial details

NCT IDNCT05227339

SponsorContinueYou, LLC

Sponsor typeINDUSTRY

Study typeINTERVENTIONAL

Primary completion2024-02-01

View on ClinicalTrials.gov More Substance Use Disorders trials